[Editors' Choice] A vaccine to kiss EBV goodbye
A nanoparticle Epstein-Barr virus glycoprotein gH/gL vaccine elicits antibodies that mediate cell type–independent protection from infection.
Source: Science Translational Medicine - Category: Biomedical Science Authors: Boyle, M. Tags: Editors ' Choice Source Type: research